Concepedia

Jahna Espinosa

JE

Statistics

Publications

2

Citations

76

H-Index

2

Active since

2013

Affiliations

CritiTech (United States)(Current)

Jahna Espinosa is an author at CritiTech (United States) specializing in pharmacy, pharmacology, and nanoparticle drug delivery.

Publications per year

2013–2015

2

Publications

2

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies

Stephen K. Williamson, Gary A. Johnson, Holly Maulhardt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 66 citations · Full text

, , +13

Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines

Sandra M. Axiak‐Bechtel, Senthil R. Kumar, Kristin K. Dank et al. · Investigational New Drugs · 2013 · 10 citations

, , +14

1–2 of 2